CW-3308
CW-3308 is an orally bioavailable PROTAC degrader targeting BRD9, constructed from a naphthyridine-based ligand, a 3-azaspiro[5.5]undecane linker, and a thalidomide-derived E3 ligase binder. This compound enables the investigation of BRD9 function and its therapeutic potential in both cellular and animal models of cancer and other diseases.
Product Specifications
Field of Research
Epigenetics & Chromatin, Pharmacology & Drug Discovery
Molecular Formula
C45H48N6O8
Molecular Weight
800.9
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog